Our results indicate that diabetes increases the levels of NFκB, NLRP3 inflammasome, and IL-1β in the hippocampus, suggesting that activation of diabetes-induced NLRP3 and enhanced secretion of IL-1β contribute to the progression of diabetic encephalopathy. The gene discussed is NFKB1; the disease is diabetic encephalopathy.